STRUCTURE-FUNCTION DYNAMICS OF NGF RECEPTORS
STRUCTURE-FUNCTION DYNAMICS OF NGF RECEPTORS
批准号:
2267158
负责人:
David E. Wolf
金额:
$26.87万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-08-01 至 1997-07-31
关键词:
biophysics clathrin computer program /software diffusion dimer flow cytometry fluidity fluorescence microscopy fluorescence spectrometry growth factor receptors image processing immunofluorescence technique immunoprecipitation laboratory mouse laboratory rabbit membrane activity membrane proteins neurotrophic factors phosphorylation protein structure function protein tyrosine kinase receptor binding site directed mutagenesis tissue /cell culture
中文摘要
一种蛋白质之间存在基本的三方关系
结构、其功能以及相对于
它必须与之相互作用的分子。这项建议集中在
这种关系对于神经生长因子受体(NGFR)所起的作用
在神经发育和修复中起着重要作用。NGFR在这两种情况下都存在
高亲和力和低亲和力的形式。低拷贝数高亲和力形式是
功能所必需的。最近,第二个组件gp140trk已经
识别,这是高亲和力结合所必需的。
我们已经证明gp75是均匀分布和自由扩散的。
在无反应细胞上,但在反应细胞上聚集和固定
细胞。我们的假设是gp140trk与gp75形成络合物,形成
高亲和力NGFR,负责固定和聚集
反应细胞上的gp75。为了检验这一假设,我们将问:
1.gp140trk的扩散和分布特性是什么?一个。
Gp140trk的分布和扩散性与
响应性?B.添加NGF是否改变了分布或
Gp140trk?C.gp75与哪些结构有关
和/或反应细胞中的gp140trk复合体?D.是扩散吗
高亲和力和低亲和力NGFR gp75和gp140trk的性质不同。
将通过以下方式研究gp140trk的成分分布
荧光显微镜。扩散测量将使用
光漂白后荧光恢复(FRAP)。
2.高亲和力的NGFR是gp75和gp140trk的复合体吗?(a.)会吗?
这个复合体是预先存在的,还是响应NGF而形成的?(B)在那里吗
这个建筑群中有不止一个gp75或gp140trk吗?
NGFR及其成分gp75和gp140trk的相对量将
在有反应和无反应的细胞上用放射性测定
约束性分析。然后将使用三种方法来解决
聚合问题:(1.)Frap;(2.)受体增溶作用;以及
(3)荧光共振能量转移(FRET)。
3.gp75-gp140trk络合是造成大规模的原因吗?
在反应细胞上观察到gp75的聚集?我们将进一步
开发一种使用视频成像FRET显微镜来确定
Gp75-gp140trk复合体在细胞表面的空间分布。
4.gp75和gp140trk的哪些结构域控制功能和物理
NGFR的特性?使用NGFR突变体,我们会问,a.是
Gp75的胞质结构域是形成复合体所必需的,gp75-
Gp140trk固定化?B.是gp140trk的胞内结构域
Gp75-gp140trk复合体的形成和固定所需的?C.IS
需要一个功能激活域吗?D.是以下项目的共识序列
是否需要与涂层坑相关联?
英文摘要
There is a fundamental tripartite relationship between a proteins's
structure, its function, and its ability to diffuse relative to the
molecules with which it must interact. This proposal concentrates on
this relationship for the nerve growth factor receptor (NGFR) which plays
an important role in neural development and repair. NGFR exists in both
high- and low-affinity forms. The low copy number high-affinity form is
required for function. Recently, a second component, gp140trk, has been
identified, which is essential for high-affinity binding.
We have shown that gp75 is homogeneously distributed and diffuses freely
on nonresponsive cells, but is aggregated and immobilized on responsive
cells. Our hypothesis is that gp140trk complexes with gp75 to form the
high affinity NGFR and is responsible for immobilizing and aggregating
gp75 on responsive cells. To test this hypothesis we will ask:
1. What are the diffusion and distribution properties of gp140trk? a.
How does gp140trk distribution and diffusibility relate to
responsiveness? b. Does addition of NGF alter the distribution or
diffusion of gp140trk? c. What structures are associated with gp75
and/or gp140trk complexes in responsive cells? d. Are the diffusion
properties of high- and low-affinity NGFR gp75 and gp140trk different.
Distribution of the components of gp140trk will be studied by
fluorescence microscopy. Diffusion measurements will be made using
fluorescence recovery after photobleaching (FRAP).
2. Is the high-affinity NGFR a complex of gp75 and gp140trk? (a.) Does
the complex pre-exist or does it form in response to NGF? (b.) Is there
more than one gp75 or gp140trk in this complex?
The relative amounts of NGFR and its components gp75 and gp140trk will
be determined on responsive and nonresponsive cells by radioactive
binding analysis. Three methods will then be used to address the
question of aggregation: (1.) FRAP; (2.) receptor solubilization; and
(3.) fluorescence resonance energy transfer (FRET).
3. Is gp75-gp140trk complexing responsible for the large scale
aggregation of gp75 observed on responsive cells? We will further
develop a new method using video imaging FRET microscopy to determine the
spatial distribution of gp75-gp140trk complexes on the cell surface.
4. Which domains of gp75 and gp140trk control the function and physical
properties of NGFR? Using NGFR mutants we will ask, a. Is the
cytoplasmic domain of gp75 required for complex formation and gp75-
gp140trk immobilization? b. Is the intracellular domain of gp140trk
required for gp75-gp140trk complex formation and immobilization? c. Is
a functional kinase domain required? d. Is the consensus sequence for
association with coated pits required?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Instrument for Single Molecule Sequencing of Alzheimer's-Relevant Genomic Oxidati
-
批准号:8464401
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2012
-
负责人:David E. Wolf
-
依托单位:
Optical Surgical Probe for Assessing Human Oral Mucosa Graft Vascularization
-
批准号:8122660
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2011
-
负责人:David E. Wolf
-
依托单位:
Device for Measuring Capillary Blood Flow and the Onset of Shock
-
批准号:8198276
-
项目类别:
-
资助金额:$22.06万
-
财政年份:2011
-
负责人:David E. Wolf
-
依托单位:
Improved Pathogen Detection by Fluorescence Correlation
-
批准号:6791620
-
项目类别:
-
资助金额:$47.89万
-
财政年份:2004
-
负责人:David E. Wolf
-
依托单位:
Optimization of Kinetics in a Novel Glucose Sensor
-
批准号:6444219
-
项目类别:
-
资助金额:$38.96万
-
财政年份:2000
-
负责人:David E. Wolf
-
依托单位:
OPTIMIZATION OF KINETICS IN A NOVEL GLUCOSE SENSOR
-
批准号:6072103
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2000
-
负责人:David E. Wolf
-
依托单位:
Optimization of Kinetics in a Novel Glucose Sensor
-
批准号:6622253
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2000
-
负责人:David E. Wolf
-
依托单位:
STRUCTURE/FUNCTION DYNAMICS OF NGF RECEPTORS
-
批准号:2614537
-
项目类别:
-
资助金额:$25.48万
-
财政年份:1993
-
负责人:David E. Wolf
-
依托单位:
STRUCTURE-FUNCTION DYNAMICS OF NGF RECEPTORS
-
批准号:2267157
-
项目类别:
-
资助金额:$25.74万
-
财政年份:1993
-
负责人:David E. Wolf
-
依托单位:
STRUCTURE/FUNCTION DYNAMICS OF NGF RECEPTORS
-
批准号:6319185
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1993
-
负责人:David E. Wolf
-
依托单位:
STRUCTURE/FUNCTION DYNAMICS OF NGF RECEPTORS
-
批准号:6393461
-
项目类别:
-
资助金额:$13.18万
-
财政年份:1993
-
负责人:David E. Wolf
-
依托单位:
STRUCTURE/FUNCTION DYNAMICS OF NGF RECEPTORS
-
批准号:2891781
-
项目类别:
-
资助金额:$25.95万
-
财政年份:1993
-
负责人:David E. Wolf
-
依托单位:
STRUCTURE/FUNCTION DYNAMICS OF NGF RECEPTORS
-
批准号:6610949
-
项目类别:
-
资助金额:$16.11万
-
财政年份:1993
-
负责人:David E. Wolf
-
依托单位:
STRUCTURE-FUNCTION DYNAMICS OF NGF RECEPTORS
-
批准号:2397752
-
项目类别:
-
资助金额:$2.26万
-
财政年份:1993
-
负责人:David E. Wolf
-
依托单位:
STRUCTURE-FUNCTION DYNAMICS OF NGF RECEPTORS
-
批准号:3415394
-
项目类别:
-
资助金额:$25.91万
-
财政年份:1993
-
负责人:David E. Wolf
-
依托单位:
STRUCTURE/FUNCTION DYNAMICS OF NGF RECEPTORS
-
批准号:6187250
-
项目类别:
-
资助金额:$33.76万
-
财政年份:1993
-
负责人:David E. Wolf
-
依托单位:
STRUCTURE-FUNCTION DYNAMICS OF NGF RECEPTORS
-
批准号:2267159
-
项目类别:
-
资助金额:$26.32万
-
财政年份:1993
-
负责人:David E. Wolf
-
依托单位:
STRUCTURE/FUNCTION DYNAMICS OF NGF RECEPTORS
-
批准号:6083873
-
项目类别:
-
资助金额:$5.35万
-
财政年份:1993
-
负责人:David E. Wolf
-
依托单位:
MEMBRANE DOMAINS AND THE CONTROL OF FERTILIZATION
-
批准号:3323387
-
项目类别:
-
资助金额:$10.06万
-
财政年份:1987
-
负责人:David E. Wolf
-
依托单位:
MEMBRANE DOMAINS & THE CONTROL OF FERTILIZATION
-
批准号:3323386
-
项目类别:
-
资助金额:$10.04万
-
财政年份:1987
-
负责人:David E. Wolf
-
依托单位:
国内基金
海外基金
登录
查看更多内容
通过Clathrin/AP2途径介导内皮细胞Occludin自噬性降解以靶向开放胶质瘤血肿瘤屏障的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:艾潇琳
-
依托单位:
GRB2/Clathrin/ESCRT介导的内吞、运输及溶酶体降解在CD7 CAR-T细胞诱导T细胞CD7阴性表达的机制研究
-
批准号:82270234
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:胡永仙
-
依托单位:
TMEM30A通过Clathrin介导的囊泡转运参与足细胞损伤的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:彭雷
-
依托单位:
活细胞高分辨率成像解析clathrin介导的内吞囊泡形成早期内体的分子机制
-
批准号:31970659
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2019
-
负责人:何康敏
-
依托单位:
ACTN4通过Clathrin依赖的内吞作用调控绒毛外滋养细胞侵袭力在子痫前期发病中的作用机制研究
-
批准号:81801482
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:张晨
-
依托单位:
Clathrin介导的内吞作用在类酵母共生菌进入褐飞虱卵巢上皮栓滤泡细胞中的作用机制
-
批准号:31871961
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:许益鹏
-
依托单位:
参知健脑方对血管性痴呆大鼠clathrin介导的NMDA受体胞吞过程的作用机制研究
-
批准号:81673910
-
项目类别:面上项目
-
资助金额:52.0万元
-
批准年份:2016
-
负责人:韩振蕴
-
依托单位:
石斑鱼网格蛋白(clathrin)介导虹彩病毒SGIV侵染宿主细胞的分子机制
-
批准号:41606183
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:王劭雯
-
依托单位:
猪miR-124调控clathrin介导的胞吞通路抑制乙脑病毒增殖的作用机制研究
-
批准号:31501921
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2015
-
负责人:杨松柏
-
依托单位:
SNX3调控膜管介导的clathrin不依赖型内吞途径循环运输的功能与机理研究
-
批准号:31571468
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2015
-
负责人:张蓉颖
-
依托单位: